These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2530794

  • 1. Paroxetine: pharmacokinetic and antidepressant effect in the elderly.
    Lundmark J, Scheel Thomsen I, Fjord-Larsen T, Manniche PM, Mengel H, Møller-Nielsen EM, Pauser H, Wålinder J.
    Acta Psychiatr Scand Suppl; 1989; 350():76-80. PubMed ID: 2530794
    [Abstract] [Full Text] [Related]

  • 2. Paroxetine plasma levels: lack of correlation with efficacy or adverse events.
    Tasker TC, Kaye CM, Zussman BD, Link CG.
    Acta Psychiatr Scand Suppl; 1989; 350():152-5. PubMed ID: 2530776
    [No Abstract] [Full Text] [Related]

  • 3. A pharmacokinetic dose titration study in adult and elderly depressed patients.
    Hebenstreit GF, Fellerer K, Zöchling R, Zentz A, Dunbar GC.
    Acta Psychiatr Scand Suppl; 1989; 350():81-4. PubMed ID: 2530795
    [No Abstract] [Full Text] [Related]

  • 4. The pharmacokinetics of paroxetine in elderly depressed patients.
    Ghose K.
    Acta Psychiatr Scand Suppl; 1989; 350():87-8. PubMed ID: 2530797
    [No Abstract] [Full Text] [Related]

  • 5. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
    Kuhs H, Schlake HP, Rolf LH, Rudolf GA.
    Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
    [Abstract] [Full Text] [Related]

  • 6. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP, Boyer WF.
    Acta Psychiatr Scand Suppl; 1989 May; 350():125-9. PubMed ID: 2530763
    [Abstract] [Full Text] [Related]

  • 7. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL, Clissold SP.
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [Abstract] [Full Text] [Related]

  • 8. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E, Pelicier Y, Archambault JC, Chabannes JP, Clerc G, Desvilles M, Guibert M, Pagot R, Poisat JL, Thobie Y.
    Acta Psychiatr Scand Suppl; 1989 Feb; 350():132-4. PubMed ID: 2530766
    [No Abstract] [Full Text] [Related]

  • 9. The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.
    Gagiano CA, Müller PG, Fourie J, Le Roux JF.
    Acta Psychiatr Scand Suppl; 1989 Feb; 350():130-1. PubMed ID: 2530765
    [No Abstract] [Full Text] [Related]

  • 10. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
    Nielsen OA, Morsing I, Petersen JS, Larsen T, Møller SE, Manniche PM, Skausig OB.
    Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
    [Abstract] [Full Text] [Related]

  • 11. A review of the metabolism and pharmacokinetics of paroxetine in man.
    Kaye CM, Haddock RE, Langley PF, Mellows G, Tasker TC, Zussman BD, Greb WH.
    Acta Psychiatr Scand Suppl; 1989 Sep; 350():60-75. PubMed ID: 2530793
    [Abstract] [Full Text] [Related]

  • 12. A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients.
    Bascara L.
    Acta Psychiatr Scand Suppl; 1989 Sep; 350():141-2. PubMed ID: 2530771
    [No Abstract] [Full Text] [Related]

  • 13. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
    Kuhs H, Rudolf GA.
    Acta Psychiatr Scand Suppl; 1989 Sep; 350():145-6. PubMed ID: 2530773
    [No Abstract] [Full Text] [Related]

  • 14. A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic.
    Miller SM, Naylor GJ, Murtagh M, Winslow G.
    Acta Psychiatr Scand Suppl; 1989 Sep; 350():143-4. PubMed ID: 2530772
    [No Abstract] [Full Text] [Related]

  • 15. A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients.
    Rickels K, Amsterdam J, Clary C, Fox I, Schweizer E, Weise C.
    Acta Psychiatr Scand Suppl; 1989 Sep; 350():117-23. PubMed ID: 2530761
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, multicentre study of paroxetine and mianserin in depression.
    Mertens C, Pintens H.
    Acta Psychiatr Scand Suppl; 1989 Sep; 350():140. PubMed ID: 2530770
    [No Abstract] [Full Text] [Related]

  • 17. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1990 Apr; 18(4):289-99. PubMed ID: 2140382
    [Abstract] [Full Text] [Related]

  • 18. Optimal dose regimen for paroxetine.
    Dunner DL, Dunbar GC.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():21-6. PubMed ID: 1531817
    [Abstract] [Full Text] [Related]

  • 19. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
    Dunbar GC, Cohn JB, Fabre LF, Feighner JP, Fieve RR, Mendels J, Shrivastava RK.
    Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
    [Abstract] [Full Text] [Related]

  • 20. Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin.
    Mertens C, Pintens H.
    Acta Psychiatr Scand; 1988 Jun; 77(6):683-8. PubMed ID: 2970203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.